GSA Capital Partners LLP Buys Shares of 107,928 Herbalife Ltd $HLF

GSA Capital Partners LLP bought a new position in Herbalife Ltd (NYSE:HLF) during the 3rd quarter, HoldingsChannel.com reports. The fund bought 107,928 shares of the company’s stock, valued at approximately $911,000.

Other institutional investors have also made changes to their positions in the company. The Manufacturers Life Insurance Company grew its stake in shares of Herbalife by 3.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,642 shares of the company’s stock valued at $316,000 after buying an additional 1,217 shares in the last quarter. Savant Capital LLC increased its position in Herbalife by 14.5% during the second quarter. Savant Capital LLC now owns 17,385 shares of the company’s stock worth $150,000 after buying an additional 2,204 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Herbalife by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,964 shares of the company’s stock valued at $517,000 after buying an additional 2,523 shares in the last quarter. Empowered Funds LLC raised its holdings in Herbalife by 12.9% during the first quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock valued at $261,000 after buying an additional 3,474 shares in the last quarter. Finally, FNY Investment Advisers LLC acquired a new stake in shares of Herbalife in the second quarter worth about $29,000.

Herbalife Stock Up 1.8%

Shares of HLF stock opened at $19.92 on Friday. Herbalife Ltd has a 12 month low of $6.20 and a 12 month high of $20.34. The firm has a market cap of $2.06 billion, a PE ratio of 9.05 and a beta of 0.84. The stock has a 50 day moving average of $15.60 and a 200-day moving average of $11.72.

Herbalife (NYSE:HLF) last announced its quarterly earnings data on Wednesday, February 18th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.03). The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.24 billion. Herbalife had a negative return on equity of 35.02% and a net margin of 4.53%.The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.36 EPS. As a group, equities analysts predict that Herbalife Ltd will post 1.57 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HLF shares. Maxim Group assumed coverage on Herbalife in a report on Tuesday, January 6th. They set a “buy” rating and a $20.00 price objective on the stock. Argus set a $15.00 price target on Herbalife in a report on Wednesday, November 26th. Weiss Ratings reissued a “hold (c)” rating on shares of Herbalife in a research report on Thursday, January 22nd. Mizuho set a $13.00 price objective on shares of Herbalife and gave the stock a “neutral” rating in a research note on Thursday, January 8th. Finally, Citigroup reiterated a “buy” rating and issued a $21.00 target price (up from $17.00) on shares of Herbalife in a research note on Thursday. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $16.60.

Key Stories Impacting Herbalife

Here are the key news stories impacting Herbalife this week:

• Positive Sentiment: Cristiano Ronaldo purchased a disclosed minority stake (reported as ~10% of the Pro2col unit), which investors have treated as a credibility and growth signal for Herbalife’s wellness/tech spinout. Cristiano Ronaldo Invests $7.5 Million Into Herbalife—Stock Surges
• Positive Sentiment: Q4 revenue (≈$1.28–1.30B) topped consensus and the company issued FY/quarter guidance in line with or slightly above Street expectations — supporting the view that top-line growth is intact. Herbalife (NYSE:HLF) Beats Q4 CY2025 Sales Expectations, Stock Jumps 11.7%
• Positive Sentiment: Analysts and quant-rank services turned more constructive: Maxim reiterated a Buy and Zacks added HLF to its Rank #1 (Strong Buy) lists, boosting short-term demand from retail and model-driven funds. Buy Rating on Herbalife Driven by Turnaround Momentum… New Strong Buy Stocks for February 20th
• Positive Sentiment: Shares hit a 52-week / multi-year high on the combined impact of the deal news, better-than-expected net sales and increased volume — momentum that can attract momentum/trend traders. Herbalife (HLF) Climbs to 3-Year High on Net Sales Beat
• Neutral Sentiment: The full Q4 earnings call transcript and slide deck are available for investors who want detailed color on product innovation, distributor trends and digital personalization initiatives — useful for modeling longer-term growth but not an immediate catalyst by itself. Herbalife Q4 2025 earnings call transcript
• Negative Sentiment: Mixed profitability signals: while revenue and operating cash flow grew, reported EPS metrics missed some consensus figures and the company showed year-over-year declines in operating profit and net income, which raises questions about margin recovery. Herbalife Ltd. (HLF) stock rises on Q4 2025 Earnings
• Negative Sentiment: Some outlets flagged an EPS miss versus consensus and a negative ROE / thin net margin — fundamentals investors watch for sustained valuation support. Herbalife Ltd (HLF) Misses Q4 Earnings and Revenue Estimates

Herbalife Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.